Table 2 Baseline characteristics of DLBCL patients
From: The critical role of RasGRP4 in the growth of diffuse large B cell lymphoma
Patient | Gender | Age | IPI/aa IPI | Stage | Extranodal Involved Organs | LDH | Maximum Diameter (cm) | SUVmax Value | AOD (Rasgrp4 expression) |
|---|---|---|---|---|---|---|---|---|---|
1 | F | 72 | 4 | IVB | 1 | (−) | 3 | 16.1 | 0.00819 |
2 | M | 66 | 3 | IIIA | 1 | (+) | 6 | 21 | 0.02483 |
3 | F | 76 | 3 | IV | 1 | (+) | 7.8 | 23 | 0.03785 |
4 | M | 22 | 2 | IVB | 3 | (+) | 14.8 | 26.9 | 0.04329 |
5 | F | 61 | 3 | IIIA | 0 | (+) | 10.5 | 17 | 0.02118 |
6 | M | 59 | 3 | IV | 2 | (+) | 7.5 | / | 0.02108 |
7 | F | 70 | 2 | IVA | 1 | (+) | 3 | 5.9 | 0.00141 |
8 | F | 69 | 4 | IIIB | 0 | / | 4.5 | 19.3 | 0.00998 |
9 | M | 64 | 1 | IVA | 2 | (+) | 6.6 | 21.9 | 0.01752 |
10 | M | 37 | 2 | IV | 1 | / | 4 | 25.3 | 0.00663 |
11 | F | 46 | 2 | IV | 2 | (−) | 19 | / | 0.0796 |
12 | F | 70 | 2 | IIIB | 0 | (−) | 4 | / | 0.00336 |
13 | F | 68 | 1 | IIA | 0 | (+) | 3.3 | 12.4 | 0.00286 |
14 | F | 54 | 0 | IVA | 2 | (−) | 5 | 12.3 | 0.01258 |
15 | F | 80 | 3 | IIB | 0 | (+) | 8 | / | 0.01853 |
16 | M | 58 | 1 | IVA | 1 | (−) | 4.5 | 20.8 | 0.00869 |
17 | F | 59 | 0 | IV | 2 | (+) | 5 | 10.2 | 0.01436 |
18 | F | 30 | 1 | IIA | 0 | (−) | 6.3 | / | 0.01246 |
19 | M | 74 | 2 | III | 0 | / | 2.8 | 15 | 0.0047 |
20 | F | 55 | 2 | IV | 2 | (+) | 4 | / | 0.01799 |
21 | F | 63 | 3 | IVA | 2 | (−) | 23 | 51 | 0.0499 |
22 | M | 43 | 0 | IIA | 0 | / | 3.7 | 19.1 | 0.00823 |
23 | F | 30 | 1 | IIA | 0 | (−) | 5.2 | 15.9 | 0.01324 |